Amgen (NASDAQ:AMGN) today announced that the Company will participate in the SunTrust Robinson Humphrey Life Sciences Summit Virtual Meeting Series. David M. Reese, M.D., executive vice president of Research and Development at Amgen, is scheduled to participate on Wednesday, May 6 at 11:00 a.m. PT (2:00 p.m. ET).
| THOUSAND OAKS, Calif., May 4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Company will participate in the SunTrust Robinson Humphrey Life Sciences Summit Virtual Meeting Series. David M. Reese, M.D., executive vice president of Research and Development at Amgen, is scheduled to participate on Wednesday, May 6 at 11:00 a.m. PT (2:00 p.m. ET). Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen’s business given by management at certain investor and medical conferences, can be found on Amgen’s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen’s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. CONTACT: Amgen, Thousand Oaks
SOURCE Amgen | ||
Company Codes: NASDAQ-NMS:AMGN |
View original content to download multimedia:
